Ulcer PepticULTRANCT06077955
Ulcers Formation After Hand-Sewn vs Stapled Gastrojejunal Anastomosis In MGB.
A study testing Mini-gastric bypass with stapled anastomosis and Mini-gastric bypass with hand-sewn anastomosis in people with Ulcer Peptic, run by Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health at 1 site in Russia.
Trial summary
We assume that the frequency of gastrojejunostomy ulcers after MGB-OAGB is associated with the peculiarities of the side-to-side gastrojejunostomy (GJS) formation, which is currently the "gold standard" for this procedure. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Ulcer Peptic
- What is being tested?
- Mini-gastric bypass with stapled anastomosis and Mini-gastric bypass with hand-sewn anastomosis
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 300 participants
- Where
- 1 siteRussia
- Study dates
- 1 Nov 2023to Apr 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Men and women aged 18 to 65;
- Body mass index over 40 kg/m2 or 35 kg/m2 in the presence of concomitant metabolic disorders (type 2 diabetes mellitus, hypertension, coronary artery disease, atherosclerosis and dyslipidemia);
- Preliminary consultation with an endocrinologist;
- Voluntary informed consent for surgical treatment;
- Voluntary informed consent to participate in a clinical trial;
- A negative test for Helicobacter pylori or a full course of eradication therapy.
Show all 15Show fewer
- Non-Inclusion Criteria:
- smoking;
- gastric ulcer disease in history;
- earlier abdominal surgery by laparotomy
- abdominal wall hernias;
- contraindications to planned operative treatment of bariatric profile based on the results of the pre-surgery evaluation of somatic status (see section "Patient's Treatment Protocol");
- for women - pregnancy planning in the next 12 months;
- mental health record;
- patients with oncological diseases;
Who cannot join
- surgical complications in the early post-surgery period related to the disruption of vital functions of organs and systems (respiratory, neurological and cardiological disorders requiring a stay in then the intensive-care unit, long-term position compression syndrome with renal impairment, venous thromboembolism);
- surgical complications in the early post-surgery period requiring repeated surgery or minimally invasive surgery (intraabdominal / intraluminal hemorrhage, failure of manual/ hardware suture on gastrointestinal organs etc.);
- positive intraoperative test for leak-proof anastomosis (injection of methylene blue solution or "bubble-test"), requiring surgical procedures for color leakage zone removal (see section "Patient's Treatment Protocol");
- poor adherence to the recommendations for gastroprotective therapy and recommendations on diet after surgery by the patient (see section "Interim control");
- patient's refusal to participate in the clinical study at any stage.
Trial locations and contacts
1 site in 1 country.
Russia1 site, 1 recruiting
- Recruiting
Almazov National Medical Research Centre
Saint Petersburg
Alexandr Neimark
About this study
Official title: The Incidence of Gastrojejunostomy Ulceration After MGB-OAGB: Comparison of Hand-Sewn and Stapled Techniques of Anastomosis Formation. Multicenter Prospective Randomized Clinical Trial Study
We assume that the frequency of gastrojejunostomy ulcers after MGB-OAGB is associated with the peculiarities of the side-to-side gastrojejunostomy (GJS) formation, which is currently the "gold standard" for this procedure. The geometry of such anastomosis leads to the formation of a narrow strip of the gastric wall between two stapler lines (between the suture from the 2nd cassette during the formation of the "small ventricle" and directly from the suture from the cassette during the GJS formation). Perhaps this section of the stomach wall is prone to ischemia, which can certainly increase the risk of ulcer formation. It is also possible that a zone with impaired blood supply may also form in the "blind pocket" above the anastomosis.
When forming a Hand-Sewn GJS of the end-to-side type, ischemia zones do not occur. The anastomosis has a more physiological geometry, there is no conflict between the lines of stapled sutures.
Read more
Thus, we put forward the assumption that a serious risk factor for the development of a GJS ulcer was eliminated when switching to a completely manual technique for the GJS formation when performing MGB-OAGB.
The study is aimed at the compare the incidence of GJS ulcers during MGB-OAGB, depending on the techniques of anastomosis formation.
Read the detailed description
Today, MGB-OAGB, a mini-gastric bypass or one anastomosis gastric bypass, is one of the most widely used bariatric procedures. This surgery was first performed by Professor R. Rutledge in 1997, having published the first data in 2001 on a sample of 1274 patients [1]. In 2014, the first consensus conference was held, at which recommendations for application and generalization of experience were adopted [2]. By 2018, the share of MGB-OAGB surgeries in the world was already 7.7% [3]. In the Russian Federation, this index for 2021 was 12%, which indicates a significant prevalence of mini-gastric bypass surgery in the Russian Federation [4]. This is facilitated by the simplicity, safety and high efficiency of this procedure in relation to obesity and metabolic disorders. Comparative studies and subsequent meta-analyses show a number of advantages over the classic Roux-en-Y gastric bypass [5, 6]. Reduction in the duration of the surgery and the reduction in the number of surgical complications are attractive for surgeons.
However, with the increase in the number of surgeries and the accumulation of experience, a number of problems associated with this surgery become apparent. Malabsorption risks are minimized by measuring the length of the common loop and cutting off a strictly defined percentage of the small intestine from digestion. Research on bile reflux effects is currently ongoing, but in order to reduce it, the surgical technique has been modified by lengthening the gastric tube [2]. One of the most serious problems is the appearance of gastrojejunostomy (GJS) ulcers. As a rule, they are difficult to treat and can cause bleeding. Their number seriously varies in different publications from 2% to 13% [7, 8]. These figures, despite the attractiveness of the new surgery, make many surgeons refrain from performing MGB-OAGB in their routine practice. The causes of ulcers are not fully understood and require further study, and it is also possible to change the technique of anastomosis.
Working Hypothesis We assume that the frequency of gastrojejunostomy ulcers after MGB-OAGB is associated with the peculiarities of the side-to-side GJS formation, which is currently the "gold standard" for this procedure. The geometry of such anastomosis leads to the formation of a narrow strip of the gastric wall between two stapler lines (between the suture from the 2nd cassette during the formation of the "small ventricle" and directly from the suture from the cassette during the GJS formation). Perhaps this section of the stomach wall is prone to ischemia, which can certainly increase the risk of ulcer formation. It is also possible that a zone with impaired blood supply may also form in the "blind pocket" above the anastomosis.
When forming a Hand-sewn GJS of the end-to-side type, ischemia zones do not occur. The anastomosis has a more physiological geometry, there is no conflict between the lines of stapled sutures.
Thus, we put forward the assumption that a serious risk factor for the development of a GJS ulcer was eliminated when switching to a completely Hand-sewn technique for the GJS formation when performing MGB-OAGB.
Purpose of the Study To compare the incidence of GJS ulcers during MGB-OAGB, depending on the techniques of anastomosis formation.
Materials and Research Methods In order to assess the target parameter and the endpoint of the study, all patients who underwent surgical treatment will undergo a video endoscopy of the upper gastrointestinal tract 6 months after surgical treatment.
As research tools, it is planned to use instrumental, laboratory and surgery equipment, as well as all other necessary material and technical equipment of the above medical institutions.
Treatment Protocol All eligible and randomized patients will undergo laparoscopic MGB-OAGB no later than 1 month after randomization and enrollment. As part of a standardized preoperative assessment, a set of examinations will be performed, see Appendix 2.
Standardized surgery protocol:
- One-time antibacterial prophylaxis is performed, activities are carried out for the induction of anesthesia, tracheal intubation and the implementation of inhalation anesthesia with mechanical ventilation in accordance with the local standards of the participating centers.
- Patient is placed in the supine position with the head of the bed elevated at 30° (Fowler's position).
- A carboxyperitoneum is created with a pressure of 12-16 mm Hg.
- Five trocars are installed in the upper mesogastrium according to the accepted technique for performing surgical interventions on the upper floor of the abdominal cavity in each specific clinical center.
- By one of the types of surgical energy (ultrasound, bipolar, monopolar) along the lesser curvature of the stomach, the lesser omentum is dissected and the omentum is entered from the omental bag at or distal to the crow's foot, the minimally necessary retrogastric adhesiolysis is performed.
- The gastroesophageal junction and the angle of His are mobilized. Then the stomach is transected using linear endoscopic staplers in such a way as to create an isolated narrow gastric tube ("small ventricle") at least 17-18 cm long and 15-20 mm wide (diameter of gastric tube used 36-39 Fr). Blue, green, gold, purple, and black cassettes (cassettes or cartridges in blue, green, black, or purple) can be used.
- Staple line hemostasis by applying clips.
- The greater omentum may be transversely incised depending on individual anatomy.
- Visualization of the ligament of Treitz.
- Measurement of the length of the small intestine at a distance of at least 5 m.
- A gastroenterostomy is performed at a distance of 150-200 cm from the ligament of Treitz using a linear stapler in group A and using a fully Hand-sewn suture in group B.
- Gastrotomy at the end section of the stapler line of the distal "small ventricle" and enterotomy at 150-200 cm from the ligament of Treitz are performed in group A. GJS is formed using a blue or purple cartridge (the height of the braces is 3.5 mm). The width of the formed anastomosis is calibrated according to the branch of the apparatus of 35-40 cm. The technological hole is closed with absorbable monofilament suture material with a biodegradation time of not more than 180 days on a pricking needle.
- Extended gastrotomy by cutting off the end stapler line (1st cassette, when forming the "small ventricle") is performed in group B. Enterotomy with a length of 35-40 mm is performed at a distance of 150-200 cm from the ligament of Treitz. GJS is formed by a manual single-row continuous suture using any absorbable monofilament suture material with a biodegradation period of not more than 180 days on a pricking needle.
- Performing an anastomosis leak test with a solution of methylene blue or bubble leak test.
- Testing for hemostasis.
- Desufflation of gas and suturing of trocar wounds are carried out.
After the surgical intervention, if necessary, the patient can be in the intensive care unit and monitoring until the stabilization of the condition, then transferred to the specialized surgical department.
Recommendations for nutrition after surgery: oral intake of light glucose-containing liquids begins on the first postoperative day (6-12 hours after surgery). On the second day after the surgery, the intake of concentrated glucose-containing and complex nutritional drinks begins.
After discharge from the hospital, the patient must adhere to the protocol diet (Appendix 3). All patients will be required to take preventive therapy with an established PPIs 40 mg daily for 6 months after surgery.
Intermediate Control From the moment of discharge from the hospital until the moment of assessment of the target parameter, remote monitoring will be carried out to control the patient's compliance (regularity of PPI intake, adherence to recommendations on the postoperative diet) and complaints, possibly associated with the early onset of erosive and ulcerative lesions of the upper gastrointestinal tract. Telephone control will be carried out in periods of 1, 2, 3 and 5 months after surgical treatment.
In the event of a premature referral of the patient or detection of complaints during the intermediate control, indicating the possible development of erosive and ulcerative lesions of the upper gastrointestinal tract, the patient will undergo a premature flexible endoscopy of the upper gastrointestinal tract. If a GJS ulcer is detected, the endpoint will prematurely be assessed as positive.
Expected Results It is expected to reveal a statistically significant reduction in the incidence of GJS ulceration when performing MGB-OAGB using a Hand-sewn anastomosis technique compared with a stapled technique.
- Conditions
- Ulcer Peptic
- Being tested
- Mini-gastric bypass with stapled anastomosis, Mini-gastric bypass with hand-sewn anastomosis
- Keywords
- bariatric, morbid obesity, ulcer of gastrojejunostomy, mini-gastric bypass, one-anastomosis gastric bypass, hand-sewn anastomosis, stapled anastomosis
- Medical subject headings
- Peptic Ulcer, Obesity, Morbid
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Mini-gastric bypass with stapled anastomosisProcedure or surgery
the stomach is transected using linear endoscopic staplers in such a way as to create an isolated narrow gastric tube ("small ventricle") at least 17-18 cm long and 15-20 mm wide (diameter of gastric tube used 36-39 Fr). • A gastroenterostomy is performed at a distance of 150-200 cm from the ligament of Treitz using a linear stapler.
Mini-gastric bypass with hand-sewn anastomosisProcedure or surgery
the stomach is transected using linear endoscopic staplers in such a way as to create an isolated narrow gastric tube ("small ventricle") at least 17-18 cm long and 15-20 mm wide (diameter of gastric tube used 36-39 Fr). • A gastroenterostomy is performed at a distance of 150-200 cm from the ligament of Treitz using a fully manual suture.
| Study group | Role | What they receive |
|---|---|---|
| Group A (control) - with stapled anastomosis | Active comparator | A variant of the surgery with the stapled formation of a gastrojejunostomy. Receives: Procedure: Mini-gastric bypass with stapled anastomosis |
| Group B (study) - with hand-sewn anastomosis | Experimental | A variant with a hand-sewn formation of a gastrojejunostomy. Receives: Procedure: Mini-gastric bypass with hand-sewn anastomosis |
What is being measured
The primary outcome is the main question the study is designed to answer.
The presence of a gastrojejunostomy ulcer
Video endoscopy of the upper gastrointestinal tract
Measured: 6 months
Secondary outcomes (3)
Erosive anastomositis
Video endoscopy of the upper gastrointestinal tract
Measured: 6 months
Time of surgery
Operation time from skin incision to completion of skin suturing
Measured: Intraoperative indicator
The amount of foreign non-absorbable material remaining in the body
The number of cartridges from staplers used during the operation is counted
Measured: Intraoperative indicator
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Oct 2023
- Study start1 Nov 2023
- Primary completionApr 2024 (estimated)
- Study completionApr 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (8)Papers the sponsor has linked to this study.
- Other trials for Ulcer PepticStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Two groups: group A, a variant of the surgery with the stapled formation of a GJS, and group B, a variant with a hand-sewn formation of a GJS.
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 300 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Aleksandr E. Neimark, Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
- Investigators
- Aleksandr Neimark, MD, PhD, Principal investigator, Almazov National Medical Research Centre
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06077955
- Sponsor's protocol ID
- 0210-22-MGB-OAGB
- Acronym
- ULTRA
- Status last verified
- Mar 2024
- First submitted
- 5 Oct 2023
- Last updated
- 2 Apr 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001 Jun;11(3):276-80. doi: 10.1381/096089201321336584.
PubMed 11433900Ramos AC, Chevallier JM, Mahawar K, Brown W, Kow L, White KP, Shikora S; IFSO Consensus Conference Contributors. IFSO (International Federation for Surgery of Obesity and Metabolic Disorders) Consensus Conference Statement on One-Anastomosis Gastric Bypass (OAGB-MGB): Results of a Modified Delphi Study. Obes Surg. 2020 May;30(5):1625-1634. doi: 10.1007/s11695-020-04519-y.
PubMed 32152841Welbourn R, Hollyman M, Kinsman R, Dixon J, Liem R, Ottosson J, Ramos A, Vage V, Al-Sabah S, Brown W, Cohen R, Walton P, Himpens J. Bariatric Surgery Worldwide: Baseline Demographic Description and One-Year Outcomes from the Fourth IFSO Global Registry Report 2018. Obes Surg. 2019 Mar;29(3):782-795. doi: 10.1007/s11695-018-3593-1. Epub 2018 Nov 12.
PubMed 30421326National Bariatric Registry. URL: https://bareoreg.ru (Accessed: 01.08.2023).
Ruiz-Tovar J, Carbajo MA, Jimenez JM, Castro MJ, Gonzalez G, Ortiz-de-Solorzano J, Zubiaga L. Long-term follow-up after sleeve gastrectomy versus Roux-en-Y gastric bypass versus one-anastomosis gastric bypass: a prospective randomized comparative study of weight loss and remission of comorbidities. Surg Endosc. 2019 Feb;33(2):401-410. doi: 10.1007/s00464-018-6307-9. Epub 2018 Jun 25.
PubMed 29943058Wang FG, Yan WM, Yan M, Song MM. Outcomes of Mini vs Roux-en-Y gastric bypass: A meta-analysis and systematic review. Int J Surg. 2018 Aug;56:7-14. doi: 10.1016/j.ijsu.2018.05.009. Epub 2018 May 16.
PubMed 29753952Mahawar KK, Reed AN, Graham YNH. Marginal ulcers after one anastomosis (mini) gastric bypass: a survey of surgeons. Clin Obes. 2017 Jun;7(3):151-156. doi: 10.1111/cob.12186. Epub 2017 Mar 20.
PubMed 28320077Baksi A, Kamtam DNH, Aggarwal S, Ahuja V, Kashyap L, Shende DR. Should Surveillance Endoscopy Be Routine After One Anastomosis Gastric Bypass to Detect Marginal Ulcers: Initial Outcomes in a Tertiary Referral Centre. Obes Surg. 2020 Dec;30(12):4974-4980. doi: 10.1007/s11695-020-04864-y. Epub 2020 Jul 27.
PubMed 32720263
Study at a glance
From the registry record, last updated by the sponsor on 2 Apr 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Incidence of Gastrojejunostomy Ulceration After MGB-OAGB: Comparison of Hand-Sewn and Stapled Techniques of Anastomosis Formation. Multicenter Prospective Randomized Clinical Trial Study
- ClinicalTrials.gov ID
- NCT06077955
- Acronym / sponsor ID
- ULTRA / 0210-22-MGB-OAGB
- Conditions
- Ulcer Peptic
- Keywords
- bariatric, morbid obesity, ulcer of gastrojejunostomy, mini-gastric bypass, one-anastomosis gastric bypass, hand-sewn anastomosis, stapled anastomosis
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 300 participants (estimated)
- Lead sponsor
- Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of HealthUniversity, hospital or other
- Study start
- 1 Nov 2023 (actual)
- Primary completion
- Apr 2024 (estimated)
- Study completion
- Apr 2025 (estimated)
- First posted
- 11 Oct 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
We assume that the frequency of gastrojejunostomy ulcers after MGB-OAGB is associated with the peculiarities of the side-to-side gastrojejunostomy (GJS) formation, which is currently the "gold standard" for this procedure. The geometry of such anastomosis leads to the formation of a narrow strip of the gastric wall between two stapler lines (between the suture from the 2nd cassette during the formation of the "small ventricle" and directly from the suture from the cassette during the GJS formation). Perhaps this section of the stomach wall is prone to ischemia, which can certainly increase the risk of ulcer formation. It is also possible that a zone with impaired blood supply may also form in the "blind pocket" above the anastomosis.
When forming a Hand-Sewn GJS of the end-to-side type, ischemia zones do not occur. The anastomosis has a more physiological geometry, there is no conflict between the lines of stapled sutures.
Thus, we put forward the assumption that a serious risk factor for the development of a GJS ulcer was eliminated when switching to a completely manual technique for the GJS formation when performing MGB-OAGB.
The study is aimed at the compare the incidence of GJS ulcers during MGB-OAGB, depending on the techniques of anastomosis formation.
Detailed description
Today, MGB-OAGB, a mini-gastric bypass or one anastomosis gastric bypass, is one of the most widely used bariatric procedures. This surgery was first performed by Professor R. Rutledge in 1997, having published the first data in 2001 on a sample of 1274 patients [1]. In 2014, the first consensus conference was held, at which recommendations for application and generalization of experience were adopted [2]. By 2018, the share of MGB-OAGB surgeries in the world was already 7.7% [3]. In the Russian Federation, this index for 2021 was 12%, which indicates a significant prevalence of mini-gastric bypass surgery in the Russian Federation [4]. This is facilitated by the simplicity, safety and high efficiency of this procedure in relation to obesity and metabolic disorders. Comparative studies and subsequent meta-analyses show a number of advantages over the classic Roux-en-Y gastric bypass [5, 6]. Reduction in the duration of the surgery and the reduction in the number of surgical complications are attractive for surgeons.
However, with the increase in the number of surgeries and the accumulation of experience, a number of problems associated with this surgery become apparent. Malabsorption risks are minimized by measuring the length of the common loop and cutting off a strictly defined percentage of the small intestine from digestion. Research on bile reflux effects is currently ongoing, but in order to reduce it, the surgical technique has been modified by lengthening the gastric tube [2]. One of the most serious problems is the appearance of gastrojejunostomy (GJS) ulcers. As a rule, they are difficult to treat and can cause bleeding. Their number seriously varies in different publications from 2% to 13% [7, 8]. These figures, despite the attractiveness of the new surgery, make many surgeons refrain from performing MGB-OAGB in their routine practice. The causes of ulcers are not fully understood and require further study, and it is also possible to change the technique of anastomosis.
Working Hypothesis We assume that the frequency of gastrojejunostomy ulcers after MGB-OAGB is associated with the peculiarities of the side-to-side GJS formation, which is currently the "gold standard" for this procedure. The geometry of such anastomosis leads to the formation of a narrow strip of the gastric wall between two stapler lines (between the suture from the 2nd cassette during the formation of the "small ventricle" and directly from the suture from the cassette during the GJS formation). Perhaps this section of the stomach wall is prone to ischemia, which can certainly increase the risk of ulcer formation. It is also possible that a zone with impaired blood supply may also form in the "blind pocket" above the anastomosis.
When forming a Hand-sewn GJS of the end-to-side type, ischemia zones do not occur. The anastomosis has a more physiological geometry, there is no conflict between the lines of stapled sutures.
Thus, we put forward the assumption that a serious risk factor for the development of a GJS ulcer was eliminated when switching to a completely Hand-sewn technique for the GJS formation when performing MGB-OAGB.
Purpose of the Study To compare the incidence of GJS ulcers during MGB-OAGB, depending on the techniques of anastomosis formation.
Materials and Research Methods In order to assess the target parameter and the endpoint of the study, all patients who underwent surgical treatment will undergo a video endoscopy of the upper gastrointestinal tract 6 months after surgical treatment.
As research tools, it is planned to use instrumental, laboratory and surgery equipment, as well as all other necessary material and technical equipment of the above medical institutions.
Treatment Protocol All eligible and randomized patients will undergo laparoscopic MGB-OAGB no later than 1 month after randomization and enrollment. As part of a standardized preoperative assessment, a set of examinations will be performed, see Appendix 2.
Standardized surgery protocol:
- One-time antibacterial prophylaxis is performed, activities are carried out for the induction of anesthesia, tracheal intubation and the implementation of inhalation anesthesia with mechanical ventilation in accordance with the local standards of the participating centers.
- Patient is placed in the supine position with the head of the bed elevated at 30° (Fowler's position).
- A carboxyperitoneum is created with a pressure of 12-16 mm Hg.
- Five trocars are installed in the upper mesogastrium according to the accepted technique for performing surgical interventions on the upper floor of the abdominal cavity in each specific clinical center.
- By one of the types of surgical energy (ultrasound, bipolar, monopolar) along the lesser curvature of the stomach, the lesser omentum is dissected and the omentum is entered from the omental bag at or distal to the crow's foot, the minimally necessary retrogastric adhesiolysis is performed.
- The gastroesophageal junction and the angle of His are mobilized. Then the stomach is transected using linear endoscopic staplers in such a way as to create an isolated narrow gastric tube ("small ventricle") at least 17-18 cm long and 15-20 mm wide (diameter of gastric tube used 36-39 Fr). Blue, green, gold, purple, and black cassettes (cassettes or cartridges in blue, green, black, or purple) can be used.
- Staple line hemostasis by applying clips.
- The greater omentum may be transversely incised depending on individual anatomy.
- Visualization of the ligament of Treitz.
- Measurement of the length of the small intestine at a distance of at least 5 m.
- A gastroenterostomy is performed at a distance of 150-200 cm from the ligament of Treitz using a linear stapler in group A and using a fully Hand-sewn suture in group B.
- Gastrotomy at the end section of the stapler line of the distal "small ventricle" and enterotomy at 150-200 cm from the ligament of Treitz are performed in group A. GJS is formed using a blue or purple cartridge (the height of the braces is 3.5 mm). The width of the formed anastomosis is calibrated according to the branch of the apparatus of 35-40 cm. The technological hole is closed with absorbable monofilament suture material with a biodegradation time of not more than 180 days on a pricking needle.
- Extended gastrotomy by cutting off the end stapler line (1st cassette, when forming the "small ventricle") is performed in group B. Enterotomy with a length of 35-40 mm is performed at a distance of 150-200 cm from the ligament of Treitz. GJS is formed by a manual single-row continuous suture using any absorbable monofilament suture material with a biodegradation period of not more than 180 days on a pricking needle.
- Performing an anastomosis leak test with a solution of methylene blue or bubble leak test.
- Testing for hemostasis.
- Desufflation of gas and suturing of trocar wounds are carried out.
After the surgical intervention, if necessary, the patient can be in the intensive care unit and monitoring until the stabilization of the condition, then transferred to the specialized surgical department.
Recommendations for nutrition after surgery: oral intake of light glucose-containing liquids begins on the first postoperative day (6-12 hours after surgery). On the second day after the surgery, the intake of concentrated glucose-containing and complex nutritional drinks begins.
After discharge from the hospital, the patient must adhere to the protocol diet (Appendix 3). All patients will be required to take preventive therapy with an established PPIs 40 mg daily for 6 months after surgery.
Intermediate Control From the moment of discharge from the hospital until the moment of assessment of the target parameter, remote monitoring will be carried out to control the patient's compliance (regularity of PPI intake, adherence to recommendations on the postoperative diet) and complaints, possibly associated with the early onset of erosive and ulcerative lesions of the upper gastrointestinal tract. Telephone control will be carried out in periods of 1, 2, 3 and 5 months after surgical treatment.
In the event of a premature referral of the patient or detection of complaints during the intermediate control, indicating the possible development of erosive and ulcerative lesions of the upper gastrointestinal tract, the patient will undergo a premature flexible endoscopy of the upper gastrointestinal tract. If a GJS ulcer is detected, the endpoint will prematurely be assessed as positive.
Expected Results It is expected to reveal a statistically significant reduction in the incidence of GJS ulceration when performing MGB-OAGB using a Hand-sewn anastomosis technique compared with a stapled technique.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
- Model description
- Two groups: group A, a variant of the surgery with the stapled formation of a GJS, and group B, a variant with a hand-sewn formation of a GJS.
| Arm | Type | Receives |
|---|---|---|
| Group A (control) - with stapled anastomosis | Active comparator | Procedure: Mini-gastric bypass with stapled anastomosisA variant of the surgery with the stapled formation of a gastrojejunostomy. |
| Group B (study) - with hand-sewn anastomosis | Experimental | Procedure: Mini-gastric bypass with hand-sewn anastomosisA variant with a hand-sewn formation of a gastrojejunostomy. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (15 listed)
- Men and women aged 18 to 65;
- Body mass index over 40 kg/m2 or 35 kg/m2 in the presence of concomitant metabolic disorders (type 2 diabetes mellitus, hypertension, coronary artery disease, atherosclerosis and dyslipidemia);
- Preliminary consultation with an endocrinologist;
- Voluntary informed consent for surgical treatment;
- Voluntary informed consent to participate in a clinical trial;
Key exclusion criteria (5 listed)
- surgical complications in the early post-surgery period related to the disruption of vital functions of organs and systems (respiratory, neurological and cardiological disorders requiring a stay in then the intensive-care unit, long-term position compression syndrome with renal impairment, venous thromboembolism);
- surgical complications in the early post-surgery period requiring repeated surgery or minimally invasive surgery (intraabdominal / intraluminal hemorrhage, failure of manual/ hardware suture on gastrointestinal organs etc.);
- positive intraoperative test for leak-proof anastomosis (injection of methylene blue solution or "bubble-test"), requiring surgical procedures for color leakage zone removal (see section "Patient's Treatment Protocol");
- poor adherence to the recommendations for gastroprotective therapy and recommendations on diet after surgery by the patient (see section "Interim control");
- patient's refusal to participate in the clinical study at any stage.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Mini-gastric bypass with stapled anastomosisthe stomach is transected using linear endoscopic staplers in such a way as to create an isolated narrow gastric tube ("small ventricle") at least 17-18 cm long and 15-20 mm wide (diameter of gastric tube used 36-39 Fr). • A gastroenterostomy is performed at a distance of 150-200 cm from the ligament of Treitz using a linear stapler. | Procedure or surgery | Group A (control) - with stapled anastomosis |
| Mini-gastric bypass with hand-sewn anastomosisthe stomach is transected using linear endoscopic staplers in such a way as to create an isolated narrow gastric tube ("small ventricle") at least 17-18 cm long and 15-20 mm wide (diameter of gastric tube used 36-39 Fr). • A gastroenterostomy is performed at a distance of 150-200 cm from the ligament of Treitz using a fully manual suture. | Procedure or surgery | Group B (study) - with hand-sewn anastomosis |
Primary outcome
The presence of a gastrojejunostomy ulcer
Time frame: 6 months
Video endoscopy of the upper gastrointestinal tract
3 secondary outcomes
Erosive anastomositis
Time frame: 6 months
Time of surgery
Time frame: Intraoperative indicator
The amount of foreign non-absorbable material remaining in the body
Time frame: Intraoperative indicator
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Apr 2024.
- Background: PubMed 11433900Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001 Jun;11(3):276-80. doi: 10.1381/096089201321336584.
- Background: PubMed 32152841Ramos AC, Chevallier JM, Mahawar K, Brown W, Kow L, White KP, Shikora S; IFSO Consensus Conference Contributors. IFSO (International Federation for Surgery of Obesity and Metabolic Disorders) Consensus Conference Statement on One-Anastomosis Gastric Bypass (OAGB-MGB): Results of a Modified Delphi Study. Obes Surg. 2020 May;30(5):1625-1634. doi: 10.1007/s11695-020-04519-y.
- Background: PubMed 30421326Welbourn R, Hollyman M, Kinsman R, Dixon J, Liem R, Ottosson J, Ramos A, Vage V, Al-Sabah S, Brown W, Cohen R, Walton P, Himpens J. Bariatric Surgery Worldwide: Baseline Demographic Description and One-Year Outcomes from the Fourth IFSO Global Registry Report 2018. Obes Surg. 2019 Mar;29(3):782-795. doi: 10.1007/s11695-018-3593-1. Epub 2018 Nov 12.
- BackgroundNational Bariatric Registry. URL: https://bareoreg.ru (Accessed: 01.08.2023).
- Background: PubMed 29943058Ruiz-Tovar J, Carbajo MA, Jimenez JM, Castro MJ, Gonzalez G, Ortiz-de-Solorzano J, Zubiaga L. Long-term follow-up after sleeve gastrectomy versus Roux-en-Y gastric bypass versus one-anastomosis gastric bypass: a prospective randomized comparative study of weight loss and remission of comorbidities. Surg Endosc. 2019 Feb;33(2):401-410. doi: 10.1007/s00464-018-6307-9. Epub 2018 Jun 25.
- Background: PubMed 29753952Wang FG, Yan WM, Yan M, Song MM. Outcomes of Mini vs Roux-en-Y gastric bypass: A meta-analysis and systematic review. Int J Surg. 2018 Aug;56:7-14. doi: 10.1016/j.ijsu.2018.05.009. Epub 2018 May 16.
- Background: PubMed 28320077Mahawar KK, Reed AN, Graham YNH. Marginal ulcers after one anastomosis (mini) gastric bypass: a survey of surgeons. Clin Obes. 2017 Jun;7(3):151-156. doi: 10.1111/cob.12186. Epub 2017 Mar 20.
- Background: PubMed 32720263Baksi A, Kamtam DNH, Aggarwal S, Ahuja V, Kashyap L, Shende DR. Should Surveillance Endoscopy Be Routine After One Anastomosis Gastric Bypass to Detect Marginal Ulcers: Initial Outcomes in a Tertiary Referral Centre. Obes Surg. 2020 Dec;30(12):4974-4980. doi: 10.1007/s11695-020-04864-y. Epub 2020 Jul 27.
- Individual participant dataSharing planned: No
Related trials for Ulcer Peptic
Active, not recruitingPhase 3
Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer
Peptic Ulcer
Active, not recruiting
To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology in Children.
Gastritis Chronic, Gastroduodenitis
RecruitingPhase 4
Efficacy and Safety of Vonorasan Versus Esomeprazole in the Treatment of Ulcers After Endoscopic Submucosal Dissection
Ulcers, Gastric
Recruiting
SPADE Clinical Trial.
Early Gastric Cancer, Adenocarcinoma of the Stomach
RecruitingObservational study
Efficacy and Safety of Esomeprazole 40 mg IV in Post-Surgical Patients Admitted to the ICU
Stress Ulcers, Reflux Episodes
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Aleksandr Neimark, MD, PhD principal investigator
Almazov National Medical Research Centre
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Mini-gastric bypass with stapled anastomosis and Mini-gastric bypass with hand-sewn anastomosis in people with Ulcer Peptic, run by Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health at 1 site in Russia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 15 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 2 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Russia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Aleksandr Neimark, MD, PhD (+79217590828, sas_spb@mail.ru), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The presence of a gastrojejunostomy ulcer (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06077955, which also lists 8 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Apr 2024.